FDA Gives Phase III Nod to Intec Parkinson’s Treatment

– Intec Pharma says it expects the Phase III trial for its Accordion Pill Levodopa to take place in the second half of 2015.   Intec Pharma Ltd. (TASE: INTP) reported today that it had received US More...